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Abstract 16 
Background 17 
Norovirus causes chronic infections in immunocompromised patients with considerable associated 18 
morbidity. It is not known whether chronic infections involve super- or re-infections or relapses. 19 
Objectives 20 
To retrospectively investigate whether longitudinal sampling in chronically infected patients 21 
demonstrates persistent infection with the same virus, or super- or re-infection.  22 
Study design 23 
Norovirus full genomes were generated from 86 longitudinal samples from 25 paediatric patients. 24 
Consensus sequences were used for phylogenetic analysis and genotyping.  25 
Results 26 
Super-infections occurred in 17% of chronically infected patients who were continuously PCR 27 
positive; including two with mixed norovirus infections. The median duration of infection was 107 28 
days longer in those with super-infections; however this was not statistically significant. A third of 29 
patients with interrupted norovirus shedding continued to be infected with the same virus despite 30 
up to 2 months of PCR negative stools, classified as a relapse. The majority (67%) of patients with 31 
interrupted shedding were re-infected with a different genotype. 32 
Conclusions 33 
Chronically infected patients who are continuously PCR positive are most likely to remain infected 34 
with the same virus; however super-infections do occur leading to mixed infection. Patients with 35 
interrupted shedding are likely to represent re-infection with a different genotype, however 36 
relapsing infections also occur.  37 
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Our findings have implications for infection control as immunosuppressed patients remain 38 
susceptible to new norovirus infections despite current or recent infection and may continue to be 39 
infectious after norovirus is undetectable in stool. The relevance to children without co-morbidities 40 
remains to be determined. 41 
Highlights 42 
 Super-infections occur in 17% of continuously shedding chronic norovirus infections 43 
 Re-infections occur in two-thirds of chronic infections with interrupted shedding 44 
 Relapses occur in a third of chronic infections with interrupted shedding 45 
 Patients are susceptible to super- and re-infection with different genotypes 46 
Keywords  47 
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Background 49 
Norovirus is a leading cause of gastroenteritis. Infections are typically self-limiting in 50 
immunocompetent hosts, with limited morbidity aside from dehydration. In immunocompromised 51 
patients however, there is a risk of chronic infection with significant associated morbidity [1]. 52 
Chronic infections are bi-phasic with an acute phase of vomiting and diarrhoea, followed by chronic 53 
viral shedding and diarrhoea lasting weeks to years. The majority of case reports describe patients to 54 
be symptomatic during this extended period of shedding, with up to 24 bowel movements per day 55 
[2]. However chronic infections can experience intermittent symptoms of diarrhoea [3] or be 56 
asymptomatic [4].  57 
The Norovirus genus is comprised of five genogroups (GI–GV), of which GI, GII and, to a limited 58 
extent, GIV cause infections in humans. Each genogroup is further classified into genotypes; GI.1–9 59 
and GII.1–22. GII.4 genotypes, which are the predominant global genotype since the mid-1990s [5], 60 
are divided into variant types. Norovirus has a dual typing system based on the polymerase (ORF1) 61 
and capsid (ORF2) sequences. 62 
Objectives 63 
We retrospectively sequence full norovirus genomes from longitudinally sampled chronic infections 64 
for genotyping and phylogenetic analysis, to determine whether patients remain persistently 65 
infected with the same strain or whether super- or re-infections occur. 66 
Study Design 67 
Eighty-six longitudinal stool samples were retrospectively sequenced from 25 paediatric patients, 68 
with two to eight samples per patient. Samples were collected between November 2012 and 69 
January 2016 from patients with persistent norovirus infections (PCR positive >1 month) for whom 70 
two or more longitudinal stool specimens were available. Patients were under the care of a UK 71 
paediatric tertiary referral hospital. Norovirus positive patients were tested weekly whilst inpatients 72 
or monthly whilst outpatients for the presence or absence of norovirus by the diagnostic Virology 73 
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laboratory using a reverse-transcriptase real-time multiplex PCR to detect norovirus GI and GII, the 74 
methods for which are described elsewhere [6].  75 
Of the 25 patients, 18 were continuously norovirus positive (continuous shedding), with a median of 76 
129 days between the first and last sequenced sample (range 7–466).  A further seven patients had a 77 
period between the first and last sequenced sample during which norovirus was not detected in 78 
stool, before once again being detected (interrupted shedding). In addition two of the 18 patients 79 
who shed norovirus continuously (Patient 63 and 73), proceeded to become norovirus PCR negative 80 
following which both became positive again. In total nine patients had interrupted norovirus 81 
shedding (median 153 days undetected, range 9–466).  82 
Norovirus genome sequencing and phylogenetic analysis are described in Supplementary Methods.  83 
Results 84 
Continuously positive patients 85 
Of the 18 patients who were continuously norovirus PCR positive, 15/18 (83%) remained infected 86 
with the same genotype throughout the study period, classified as persistent infections (Table 1). 87 
The longitudinal samples from each of these patients cluster together on the phylogenetic tree 88 
(Figure 1), indicating these patients remained infected not only with the same genotype but with the 89 
same virus.  90 
Three of the 18 (17%) patients with continuous shedding had evidence of infection with a second 91 
genotype occurring during the study period (Patients 73, 65 and 101), classified as super-infections. 92 
Super-infection is proven for two patients (Patient 65 and Patient 101) in whom co-infection with 93 
two different genotypes was detected in a single sample. Patient 73 was initially infected with a 94 
GII.Pe_GII.4 virus then became infected with GII.P16_GII.17, although a mixture of the two 95 
genotypes in the same sample was not detected.  Patient 73 was continually positive for norovirus in 96 
stool; the interval between detection of GII.Pe_GII.4 and of GII.P16_GII.17 was 22 days with an 97 
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additional positive stool sample taken during this interval (not available for sequencing). We cannot 98 
confirm whether Patient 73 cleared GII.Pe_GII.4 prior to infection with GII.P16_GII.17 or whether a 99 
temporary mixed infection occurred, however given the short interval between positive PCR tests 100 
(1–2 weeks), the latter is most probable.  101 
These data suggest that in patients who are continuously norovirus PCR positive, super-infection 102 
occurs in a sixth (17%) of cases. The median duration of infection was 322 days (range 58–738 days) 103 
in the three patients who had a super-infection and 215 days (range 14–711 days) in the 15 who did 104 
not. The duration of infection was not significantly different (P = 0.360). 105 
Patients with interrupted norovirus shedding  106 
Of the nine patients who become norovirus PCR negative and then positive again, five (Patients 34, 107 
68, 73, 147 and 176) acquired a second virus with a different genotype to the first, classified as re-108 
infection (Table 1). For Patient 73 this was the second incidence of re-infection, the first having 109 
occurred whilst continuously norovirus PCR positive (Supplementary Figure 1). 110 
Another of the nine patients, Patient 63, appeared to be infected with the same genotype 111 
(GII.P21_GII.3) after a period of 466 days during which norovirus was undetectable by PCR. 112 
Phylogenetic analysis revealed the second virus to be a different variant of GII.P21_GII.3, since the 113 
sequences from before and after the PCR negative period do not cluster together (Figure 1).  114 
Thus the majority (6/9, 67%) of patients with interrupted norovirus shedding had been re-infected 115 
with a different genotype or variant. 116 
For the remaining three patients (Patients 31, 72 and 75), the second virus was of the same 117 
genotype, clustering with the earlier virus in the phylogenetic analysis tree (Figure 1), classified as 118 
relapse.  This suggests cryptogenic persistence of the first virus. The three relapse patients had the 119 
shortest intervals during which norovirus was undetectable; less than two months compared to 2–15 120 
months for those who were re-infected with a new genotype or variant.  121 
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Single Nucleotide Variants in longitudinal samples 122 
Excluding those patients with mixed infections, in the patients who were continually infected with 123 
the same virus there was a strong positive correlation between the number of consensus sequence 124 
pairwise single nucleotide variants (SNVs) and the number of days separating specimen collection (R2 125 
0.775, P <0.001) (Supplementary Figure 2) with up to 131 SNVs accumulating across the genome 126 
over 445 days.  127 
Discussion 128 
We use full genome sequencing to show that super-infection and re-infection occurs in patients in 129 
whom norovirus can be detected over long periods.  When the virus is shed continuously, super-130 
infection was detected in a sixth (17%) of patients while re-infections accounted for the majority 131 
(67%) of cases where norovirus was detected after interrupted shedding. Whether a lack of 132 
protection against super- and re-infection extends to children without comorbidities remains to be 133 
determined.  134 
Conversely, relapse was identified in patients in whom norovirus shedding was interrupted for up to 135 
two months.  These data may have implications for clinical practice; chronically infected patients 136 
who appear to clear norovirus may still harbour persistent but undetectable virus.  Whether or not 137 
these patients present a transmission risk is not known.  However, a prudent course of action would 138 
be to consider immunosuppressed patients who have cleared virus after a chronic infection as 139 
potentially infectious for up to 2-3 months following the last positive stool and to continue PCR 140 
surveillance for this period. Given the small sample size in this study (three patients relapsing) a 141 
larger study is required to confirm these findings.  142 
Our data confirms previous observations that viruses persistently infecting immunocompromised 143 
patients are continuously mutating, leading to the accumulation of SNVs [3, 7]. The resulting intra-144 
host population can be observed as a heterogeneous quasispecies which some have suggested may 145 
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be a reservoir for the emergence of novel viral variants [7, 8], however the estimated rarity of such 146 
events has led to the conclusion that immunosuppressed hosts are not the principle source of novel 147 
variants at the epidemiological scale [9].   148 
Mixtures of norovirus strains have been detected in individuals in oyster-borne norovirus outbreaks 149 
[10, 11]; to our knowledge this is the first identification of mixed genotypes within a single host in 150 
sporadic infections.  Co-infecting norovirus strains within an individual provides the opportunity for 151 
viral recombination to occur, a feature that is known to be important in norovirus evolution and has 152 
been suggested to contribute to the emergence of new pandemic strains [12].  153 
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Figure titles 
Table 1. Summary of longitudinally sampled norovirus infections. The occurrence of re-infection is 
inferred from phylogenetic analysis of norovirus full genome sequences 
Figure 1. Full genome maximum likelihood phylogeny of longitudinal norovirus sequences. 
Sequences are labelled with a unique patient number (Px, NORO/XX) and serial longitudinal 
numbering (e.g. NORO/XX-1). The node shape and colour indicates whether the position on the tree 
suggests persistence of the same virus, re-infection with a  different genotype or re-infection with a 
different strain of the same genotype. Co-infections with multiple genotypes (Patient 65 and 101) 
are not shown since reliable consensus sequences for phylogenetic analysis cannot be generated. 
Footnote: Longitudinal samples from Patients 58 and 63 (63-1 and 63-2) do not cluster as closely 
together as longitudinal samples from other patients; 445 and 135 days had passed between the 
longitudinal samples therefore is consistent with accumulation of mutations over time. The second 
sample from patient 58 clusters closely with samples from patient 68 and the early samples from 
Patient 63 cluster with samples from Patient 61; these patients were epidemiologically linked (data 
not shown).  
Supplementary Figure 1. Timeline of norovirus detection in Patient 73. Orange markers indicate 
detection of norovirus GII.Pe_GII.4, blue detection of GII.P16_GII.17 and green detection of 
GII.P21_GII.3. Grey markers indicate norovirus positive samples that were not availbale for 
sequencing. Black markers with a Ct value of zero indicate norovirus was not detected by RT-qPCR. 
Supplementary Figure 2. Number of intra-host pairwise single nucleotide variants (SNVs) across 
norovirus full genomes in longitudinally sampled norovirus infections, plotted against number of 
days separating the samples.  
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